Diabetic retinopathy: targeting vasoregression

Diabetes. 2011 Jan;60(1):9-16. doi: 10.2337/db10-0454.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiopoietin-1 / physiology
  • Animals
  • Cell Movement
  • Diabetic Retinopathy / pathology
  • Diabetic Retinopathy / physiopathology
  • Diabetic Retinopathy / therapy*
  • Erythropoietin / physiology*
  • Humans
  • Hyperglycemia / physiopathology
  • Inflammation / physiopathology
  • Mice
  • Mice, Transgenic
  • Neovascularization, Pathologic / pathology
  • Neovascularization, Physiologic
  • Receptor, TIE-2 / physiology
  • Retina / pathology
  • Retina / physiology
  • Vascular Endothelial Growth Factor A / physiology

Substances

  • Angiopoietin-1
  • Vascular Endothelial Growth Factor A
  • Erythropoietin
  • Receptor, TIE-2